Medicenna Therapeutics Corp(MDNA-T)TSX
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Medicenna Therapeutics Corp
2 Bloor Street W.7th Floor
Toronto ON M4W 3E2 CAN
https://www.medicenna.com
Profile
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors, BiSKITs represents the novel platform comprised of Bifunctional SuperKine ImmunoTherapies.
Key Executives
| Name | Title |
|---|---|
| Fahar Merchant | CEO/Chairman of the Board/Director/President |
| Rosemina Merchant | Other Executive Officer |
| David Hyman | CFO |